3,4-dihydroxyphenylglycol has been researched along with Metabolic Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dawood, T; Dixon, JB; Eikelis, N; Esler, MD; Grima, MT; Lambert, EA; Lambert, GW; Masuo, K; Nestel, PJ; Paul, E; Richards, K; Sari, CI; Schlaich, MP; Straznicky, NE | 1 |
| Dixon, JB; Eikelis, N; Grima, MT; Karapanagiotidis, S; Lambert, EA; Lambert, GW; Marusic, P; Nestel, PJ; Richards, K; Sari, CI; Schlaich, MP; Straznicky, NE; Wong, C | 1 |
1 trial(s) available for 3,4-dihydroxyphenylglycol and Metabolic Syndrome
| Article | Year |
|---|---|
A randomized controlled trial of the effects of pioglitazone treatment on sympathetic nervous system activity and cardiovascular function in obese subjects with metabolic syndrome.
Topics: Blood Pressure; Diastole; Double-Blind Method; Echocardiography, Doppler; Endothelium, Vascular; Female; Glucose Tolerance Test; Humans; Hyperinsulinism; Hypertension; Hypoglycemic Agents; Male; Metabolic Syndrome; Methoxyhydroxyphenylglycol; Middle Aged; Models, Biological; Norepinephrine; Obesity; Pioglitazone; Placebos; Sympathetic Nervous System; Thiazolidinediones; Tritium | 2014 |
1 other study(ies) available for 3,4-dihydroxyphenylglycol and Metabolic Syndrome
| Article | Year |
|---|---|
The effects of dietary weight loss on indices of norepinephrine turnover: modulatory influence of hyperinsulinemia.
Topics: Body Mass Index; Diet, Reducing; Dihydroxyphenylalanine; Down-Regulation; Energy Metabolism; Female; Humans; Hyperinsulinism; Male; Metabolic Syndrome; Methoxyhydroxyphenylglycol; Middle Aged; Norepinephrine; Obesity; Sympathetic Nervous System; Weight Loss; White People | 2014 |